Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
Authors:
Open Access
- 1 July 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 9 (7) , e168
Abstract
Noscopy program between 2005 and 2010. After an initial FIT-based hemoglobin (Hb) measurement, stool samples were kept frozen at -80 °C until analysis. Twenty randomly selected participants with initial measurements ranging from 10 to 100 μg Hb/g feces were included. Ten quantitative FITs were investigated in parallel. A defined stool amount was extracted using each manufacturer's brand-specific fecal sampling device and stored at 5 °C, 20 °C, and 35 °C, respectively. After 1, 4, 5, and 7 days, the samples were analyzed blinded. Median fecal Hb concentrations and positivity rates were calculated. Results: Mean age of the participants was 67 years (range: 56–80 years) and 60% were male. The most advanced finding at screening colposcopy was advanced adenoma in five and non-advanced adenoma in eight cases. Hyperplastic polyps were found in two participants and five participants were without any findings. At 5 °C storage temperature, almost all FITs showed fairly stable results throughout the 7-day observation period. At 20 °C, most FITs still showed fairly stable results over 4 days, whereas positivity rates significantly declined from day 4 on for most FITs at 35 °C. Major differences regarding the sample stability between FITs were observed. Conclusion: FIT-specific Hb decay according to ambient temperature and time period between sampling and test evaluation requires careful consideration in the design of FIT-based screening programs....Keywords
This publication has 27 references indexed in Scilit:
- Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in GermanyClinical Gastroenterology and Hepatology, 2017
- Screening for Colorectal CancerJAMA, 2016
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Long-Term Mortality after Screening for Colorectal CancerNew England Journal of Medicine, 2013
- Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopyEuropean Journal of Cancer, 2013
- Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancerActa Oncologica, 2013
- Faecal haemoglobin concentration is related to severity of colorectal neoplasiaJournal of Clinical Pathology, 2013
- European guidelines for quality assurance in colorectal cancer screening and diagnosis. – First Edition Faecal occult blood testingEndoscopy, 2012
- Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-upGut, 2011
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An UpdateAmerican Journal of Gastroenterology, 2008